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Conflicting regulations on medicines and controlled drugs may expose 
pharmacists to criminal liability — the law must swiftly change 
Contradictions in misuse of drugs regulations mean there are ways in which pharmacists 
dispensing controlled drugs could be seen to be breaking the law. Two decades after their 
last revision, these regulations are surely due a rethink. 
 
There are inconsistences in the regulations surrounding controlled drugs. 
Exactly which type of health professional can prescribe specific drugs is open to 
interpretation, but it is the pharmacist who dispenses these drugs who could be liable to 
criminal prosecution. 
Laying out the law 
Under the Misuse of Drugs Act 1971 (MDA) possession, production and supply, import or 
export of controlled drugs is totally prohibited — except under licence from the Home 
Secretary, or as allowed by regulations,1 (ss. 3−5) including the Misuse of Drugs Regulations 
2001 (MDRs).2 
While it is illegal to supply a controlled drug under s.4 of the MDA, a pharmacist may lawfully 
do so in accordance with provisions in reg.16 of the MDRs. Similarly, a patient is not guilty of 
the crime of possession of a controlled drug if it has been prescribed to them by an 
appropriate practitioner.2 (reg. 10(2)) 
Appropriate practitioners may write prescriptions for prescription-only medicines (POMs) by 
virtue reg. 214 of the Human Medicines Regulations 2012 (HMRs). Doctors, dentists, 
supplementary prescribers (SPs), nurse independent prescribers, and pharmacist 
independent prescribers are appropriate practitioners in relation to all POMs; while 
independent prescribers from healthcare professions (such as podiatrist independent 
prescribers) and “approved country health professionals” (that is, EU practitioners) are 
appropriate practitioners for certain POMs defined within the regulation. 
A physiotherapist independent prescriber, for example, is an appropriate practitioner in 
relation to any POM, unless it contains a substance or product specified in Schedule 1, 2 or 
3 to the MDRs other than dihydrocodeine; fentanyl; morphine; oxycodone; or temazepam.3 
(reg. 214(5B)) Schedule 1, 2 and 3 controlled drugs are designated by the HMRs as “products 
subject to special medical prescription.”3 (reg. 213(3))  
Who can prescribe what? 
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Unfortunately, additional conditions for these “special medical prescriptions” are included not 
in the HMRs but in reg. 15 (‘Form of prescriptions’) of the MDRs. This regulation includes 
requirements that will be familiar to pharmacists, such as including the total quantity of the 
drug in both words and figures.  
There are, of course, areas of overlap between medicines and drugs, but this fact is not well-
served by provisions in the MDRs, which are unclear and even contradictory. For instance, 
controlled drugs included in reg. 214 of the HMRs are omitted from the MDRs, while other 
drugs are added; this creates a degree of ambiguity around who can prescribe what.4 In the 
example of physiotherapist independent prescribers, the MDRs only permit physiotherapist 
IPs to prescribe the controlled drugs listed in reg. 214(5) of the HMRs for administration by a 
specified route (usually oral), plus two benzodiazepines that are not “products subject to 
special medical prescription.” 
Independent prescribers including nurses and pharmacists, and physiotherapists and 
podiatrists are specifically authorised by regs. 6B and 6C the MDRs to prescribe controlled 
drugs; but, surprisingly, there is no equivalent provision for doctors and dentists, or 
radiographers and paramedics. While doctors and dentists are permitted by custom to 
prescribe controlled drugs, an interpretation of the law is that physiotherapists and 
podiatrists are not.5-10 
This incongruity between relatively recent medicines regulations and ageing drugs legislation 
has been discussed at length;4 however, there is also a significant degree of internal 
inconsistency within the MDRs themselves, which requires discussion and swift amendment. 
Open to interpretation 
Within the MDRs, the definition of a prescription states that it must be issued by a doctor, a 
nurse independent prescriber, a pharmacist independent prescriber, a supplementary 
prescriber or a dentist.2 (reg. 2) In unequivocally stating that only those groups can write 
prescriptions for controlled drugs, reg. 2 of the MDRs directly contradicts reg. 6C, which 
explicitly authorises both physiotherapist and podiatrist independent prescribers to prescribe 
medicines in this category.  
One may interpret this in two ways. The first: a document written by a physiotherapist or 
podiatrist independent prescriber, which is otherwise fully compliant with all the requirements 
of reg.15 of the MDRs, would not authorise the supply of any Schedule 1, 2 or 3 controlled 
drugs, because “prescriptions” cannot be written by these practitioners. The authorisation in 
reg. 6C is therefore meaningless. Yet, current guidance from the Royal Pharmaceutical 
Society, the Chartered Society of Physiotherapy, and the Pharmaceutical Services 
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Negotiating Committee — among others — specifies these groups may prescribe the 
controlled drugs specified in reg. 6C of the MDRs.10, 11 (p. 1706), 12-14 
In a second interpretation, one might determine that the definition of a prescription is invalid, 
in which case doctors and dentists cannot write prescriptions for controlled drugs because 
there is no equivalent to reg. 6C that authorises them to do so. Their authorisation to 
prescribe is implied by their inclusion in the definition of a prescription, which is now 
redundant. 
At present, only nurse and pharmacist independent prescribers are authorised by each of 
the necessary elements, namely: regulation 214 of the HMRs; and regulations 2 and 6B of 
the MDRs to write prescriptions for Schedule 1, 2 and 3 controlled drugs. There would 
appear to be no workable solution to this that does not require a change to the definition of a 
prescription and/or explicit authorisation for doctors and dentists to prescribe controlled 
drugs as afforded to other groups by regs. 6B and 6C. 
Internal inconsistencies of this kind exist throughout the MDRs. Regulation 6(2) states that 
any person who has in their possession a controlled drug that has been supplied against the 
prescription of a doctor or dentist, a registered nurse, a pharmacist independent prescriber, 
a physiotherapist independent prescriber, a chiropodist (not podiatrist, as specified in the 
HMRs) independent prescriber, or a supplementary prescriber, may supply that drug to any 
pharmacist for the purpose of destruction. This would appear to state that each of these 
groups may prescribe controlled drugs, which cannot be true as the law — however you 
choose to interpret it — is currently written. 
Why this matters for pharmacists 
Pharmacists wondering what this regulation means for them should know that poor drafting 
of this kind affects them — as the suppliers of controlled drugs — much more than it does 
those who write prescriptions for them. 
The prescriber would not commit any offence in writing what they believed was a valid 
prescription, but both the pharmacist and the patient would commit the offences of supply 
and possession, respectively,1 (ss. 4-5) as no lawful order would exist that fulfils the 
requirements of regs. 8 to 10 of the MDRs.  
At present, any pharmacist dispensing a controlled drug prescription issued by either a 
physiotherapist or podiatrist independent prescriber (or by a doctor or dentist, depending on 
which interpretation they prefer) would be doing so unlawfully within the letter of the MDRs. 
Given the current guidance in this area, however, it seems unlikely that either a prosecution 
or fitness-to-practice proceedings would be the likely outcome of doing so. Nonetheless, this 
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leniency would be at the discretion of the Crown Prosecution Service or General 
Pharmaceutical Council. 
Inconsistently drafted laws must change 
Inconsistent and ambiguous drafting is not limited to just one area of the MDRs. As already 
stated, there are major inconsistencies between medicines regulations originating within the 
Department of Health and Social Care, and the drugs legislation arising from the Home 
Office, especially where these two areas of law overlap. 
Elsewhere, regulations 8 and 9 of the MDRs deal with the production and supply of 
Schedule 2, 3, 4 and 5 controlled drugs. Rather than dealing with each of these prohibited 
acts for all schedules of controlled drugs within its own separate regulation, these have been 
organised in a way that deals with both acts simultaneously: once for drugs in Schedules 2 
and 5; and again for Schedules 3 and 4. Although both deal with the same actions, there is 
little correlation between the two regulations. For example, persons authorised to supply 
Schedule 2 and 5 controlled drugs by paragraphs 2(d) and 2 (da) of reg. 8 are authorised to 
supply Schedule 3 and 4 controlled drugs by paragraph 3(b) of reg. 9. There appears to be 
no reason other than indifferent drafting to explain why these regulations should not 
correlate. 
The Misuse of Drugs Regulations in the form that we currently recognise them first came into 
force some fourteen years after the Misuse of Drugs Act received its Royal Assent.15 
Another sixteen years passed before these regulations were revoked and re-enacted, with 
amendments, in December 2001.2 As the twentieth anniversary of that date approaches, it is 
surely time to revisit these regulations with a view to ensuring that they are clear, 
unambiguous, and compatible with all other UK laws. 
Cathal Thomas Gallagher, reader in healthcare ethics and law, Department of Clinical and 
Pharmaceutical Sciences, University of Hertfordshire. 
The views and opinions expressed in this article are those of the author and do not 
necessarily reflect the official position of the University of Hertfordshire. 
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